phenyl-n-tert-butylnitrone and Hyperglycemia

phenyl-n-tert-butylnitrone has been researched along with Hyperglycemia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farrokhnia, N; Lennmyr, F; Roos, MW; Terént, A1
Floyd, RA; Jacob, JM; Kotake, Y; Tabatabaie, T; Wallis, G1
Bray, TM; Chen, G; Ho, E1
Brownlee, M; Edelstein, D; Mullarkey, CJ1

Other Studies

4 other study(ies) available for phenyl-n-tert-butylnitrone and Hyperglycemia

ArticleYear
Experimental treatment for focal hyperglycemic ischemic brain injury in the rat.
    Experimental brain research, 2005, Volume: 167, Issue:2

    Topics: Animals; Blood Glucose; Body Temperature; Brain Ischemia; Butadienes; Carbon Dioxide; Cyclic N-Oxides; Enzyme Inhibitors; Hyperglycemia; Male; Neurologic Examination; Neuroprotective Agents; Nitriles; Nitrogen Oxides; Oxygen; Pyrimidines; Rats; Rats, Sprague-Dawley; Tetrazolium Salts; Time Factors

2005
Spin trapping agent phenyl N-tert-butylnitrone protects against the onset of drug-induced insulin-dependent diabetes mellitus.
    FEBS letters, 1997, Apr-28, Volume: 407, Issue:2

    Topics: Animals; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Electron Spin Resonance Spectroscopy; Glycated Hemoglobin; Hyperglycemia; Islets of Langerhans; Male; Mice; Mice, Inbred BALB C; Nitrogen Oxides; Spin Trapping; Streptozocin; Weight Loss

1997
Alpha-phenyl-tert-butylnitrone (PBN) inhibits NFkappaB activation offering protection against chemically induced diabetes.
    Free radical biology & medicine, 2000, Feb-15, Volume: 28, Issue:4

    Topics: Alloxan; Animals; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Free Radicals; Hyperglycemia; Islets of Langerhans; Male; Mice; NF-kappa B; Nitrogen Oxides; Reactive Oxygen Species; Spin Labels; Streptozocin

2000
Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes.
    Biochemical and biophysical research communications, 1990, Dec-31, Volume: 173, Issue:3

    Topics: Arteriosclerosis; Catalase; Cell Membrane; Cyclic N-Oxides; Cytochrome c Group; Diabetes Complications; Diabetes Mellitus; Electron Spin Resonance Spectroscopy; Free Radicals; Glucose; Humans; Hyperglycemia; Linoleic Acid; Linoleic Acids; Lipid Peroxidation; Nitroblue Tetrazolium; Nitrogen Oxides; Schiff Bases; Spin Labels; Superoxide Dismutase

1990